0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dog Prescription Drugs Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-7R7592
Home | Market Reports | Pets & Animals| Animal Products & Services| Pet Food & Supplies
Global Dog Prescription Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Dog Prescription Drugs Market Research Report 2024

Code: QYRE-Auto-7R7592
Report
February 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dog Prescription Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Dog Prescription Drugs Market

Dog Prescription Drugs Market

Dog prescription drug is a kind of animal prescription. Animal prescription drug is a prescription drug used to prevent, treat, diagnose, or purposefully regulate an animal's physiology. Animal prescription drugs mainly include: serum products, vaccines, diagnostic products, micro-ecological products, chemicals, antibiotics, biochemical drugs, radioactive drugs and external insecticides, disinfectants, etc.
The global Dog Prescription Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Dog Prescription Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dog Prescription Drugs.

Report Scope

The Dog Prescription Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dog Prescription Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dog Prescription Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Dog Prescription Drugs Market Report

Report Metric Details
Report Name Dog Prescription Drugs Market
CAGR 5%
Segment by Type
  • Oral Type
  • Smear Type
  • Injection Type
  • Spray Type
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Elanco Animal Health, Ceva Sante Animale, MSD Animal Health, Zoetis, Virbac, Dechra, Vetoquinol, Animalcare Group, Ourofino Saude Animal, Boehringer Ingelheim
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dog Prescription Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Dog Prescription Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Dog Prescription Drugs Market report?

Ans: The main players in the Dog Prescription Drugs Market are Elanco Animal Health, Ceva Sante Animale, MSD Animal Health, Zoetis, Virbac, Dechra, Vetoquinol, Animalcare Group, Ourofino Saude Animal, Boehringer Ingelheim

What are the Application segmentation covered in the Dog Prescription Drugs Market report?

Ans: The Applications covered in the Dog Prescription Drugs Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Dog Prescription Drugs Market report?

Ans: The Types covered in the Dog Prescription Drugs Market report are Oral Type, Smear Type, Injection Type, Spray Type

1 Dog Prescription Drugs Market Overview
1.1 Product Overview and Scope of Dog Prescription Drugs
1.2 Dog Prescription Drugs Segment by Type
1.2.1 Global Dog Prescription Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Oral Type
1.2.3 Smear Type
1.2.4 Injection Type
1.2.5 Spray Type
1.3 Dog Prescription Drugs Segment by Application
1.3.1 Global Dog Prescription Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Dog Prescription Drugs Market Size Estimates and Forecasts
1.4.1 Global Dog Prescription Drugs Revenue 2019-2030
1.4.2 Global Dog Prescription Drugs Sales 2019-2030
1.4.3 Global Dog Prescription Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dog Prescription Drugs Market Competition by Manufacturers
2.1 Global Dog Prescription Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dog Prescription Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dog Prescription Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Dog Prescription Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dog Prescription Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dog Prescription Drugs, Product Type & Application
2.7 Dog Prescription Drugs Market Competitive Situation and Trends
2.7.1 Dog Prescription Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dog Prescription Drugs Players Market Share by Revenue
2.7.3 Global Dog Prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dog Prescription Drugs Retrospective Market Scenario by Region
3.1 Global Dog Prescription Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dog Prescription Drugs Global Dog Prescription Drugs Sales by Region: 2019-2030
3.2.1 Global Dog Prescription Drugs Sales by Region: 2019-2024
3.2.2 Global Dog Prescription Drugs Sales by Region: 2025-2030
3.3 Global Dog Prescription Drugs Global Dog Prescription Drugs Revenue by Region: 2019-2030
3.3.1 Global Dog Prescription Drugs Revenue by Region: 2019-2024
3.3.2 Global Dog Prescription Drugs Revenue by Region: 2025-2030
3.4 North America Dog Prescription Drugs Market Facts & Figures by Country
3.4.1 North America Dog Prescription Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dog Prescription Drugs Sales by Country (2019-2030)
3.4.3 North America Dog Prescription Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dog Prescription Drugs Market Facts & Figures by Country
3.5.1 Europe Dog Prescription Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dog Prescription Drugs Sales by Country (2019-2030)
3.5.3 Europe Dog Prescription Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dog Prescription Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Dog Prescription Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dog Prescription Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Dog Prescription Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dog Prescription Drugs Market Facts & Figures by Country
3.7.1 Latin America Dog Prescription Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dog Prescription Drugs Sales by Country (2019-2030)
3.7.3 Latin America Dog Prescription Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dog Prescription Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Dog Prescription Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dog Prescription Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dog Prescription Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Dog Prescription Drugs Sales by Type (2019-2030)
4.1.1 Global Dog Prescription Drugs Sales by Type (2019-2024)
4.1.2 Global Dog Prescription Drugs Sales by Type (2025-2030)
4.1.3 Global Dog Prescription Drugs Sales Market Share by Type (2019-2030)
4.2 Global Dog Prescription Drugs Revenue by Type (2019-2030)
4.2.1 Global Dog Prescription Drugs Revenue by Type (2019-2024)
4.2.2 Global Dog Prescription Drugs Revenue by Type (2025-2030)
4.2.3 Global Dog Prescription Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Dog Prescription Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dog Prescription Drugs Sales by Application (2019-2030)
5.1.1 Global Dog Prescription Drugs Sales by Application (2019-2024)
5.1.2 Global Dog Prescription Drugs Sales by Application (2025-2030)
5.1.3 Global Dog Prescription Drugs Sales Market Share by Application (2019-2030)
5.2 Global Dog Prescription Drugs Revenue by Application (2019-2030)
5.2.1 Global Dog Prescription Drugs Revenue by Application (2019-2024)
5.2.2 Global Dog Prescription Drugs Revenue by Application (2025-2030)
5.2.3 Global Dog Prescription Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Dog Prescription Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Elanco Animal Health
6.1.1 Elanco Animal Health Corporation Information
6.1.2 Elanco Animal Health Description and Business Overview
6.1.3 Elanco Animal Health Dog Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Elanco Animal Health Dog Prescription Drugs Product Portfolio
6.1.5 Elanco Animal Health Recent Developments/Updates
6.2 Ceva Sante Animale
6.2.1 Ceva Sante Animale Corporation Information
6.2.2 Ceva Sante Animale Description and Business Overview
6.2.3 Ceva Sante Animale Dog Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ceva Sante Animale Dog Prescription Drugs Product Portfolio
6.2.5 Ceva Sante Animale Recent Developments/Updates
6.3 MSD Animal Health
6.3.1 MSD Animal Health Corporation Information
6.3.2 MSD Animal Health Description and Business Overview
6.3.3 MSD Animal Health Dog Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 MSD Animal Health Dog Prescription Drugs Product Portfolio
6.3.5 MSD Animal Health Recent Developments/Updates
6.4 Zoetis
6.4.1 Zoetis Corporation Information
6.4.2 Zoetis Description and Business Overview
6.4.3 Zoetis Dog Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zoetis Dog Prescription Drugs Product Portfolio
6.4.5 Zoetis Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Corporation Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Dog Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Virbac Dog Prescription Drugs Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Dechra
6.6.1 Dechra Corporation Information
6.6.2 Dechra Description and Business Overview
6.6.3 Dechra Dog Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Dechra Dog Prescription Drugs Product Portfolio
6.6.5 Dechra Recent Developments/Updates
6.7 Vetoquinol
6.6.1 Vetoquinol Corporation Information
6.6.2 Vetoquinol Description and Business Overview
6.6.3 Vetoquinol Dog Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Vetoquinol Dog Prescription Drugs Product Portfolio
6.7.5 Vetoquinol Recent Developments/Updates
6.8 Animalcare Group
6.8.1 Animalcare Group Corporation Information
6.8.2 Animalcare Group Description and Business Overview
6.8.3 Animalcare Group Dog Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Animalcare Group Dog Prescription Drugs Product Portfolio
6.8.5 Animalcare Group Recent Developments/Updates
6.9 Ourofino Saude Animal
6.9.1 Ourofino Saude Animal Corporation Information
6.9.2 Ourofino Saude Animal Description and Business Overview
6.9.3 Ourofino Saude Animal Dog Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Ourofino Saude Animal Dog Prescription Drugs Product Portfolio
6.9.5 Ourofino Saude Animal Recent Developments/Updates
6.10 Boehringer Ingelheim
6.10.1 Boehringer Ingelheim Corporation Information
6.10.2 Boehringer Ingelheim Description and Business Overview
6.10.3 Boehringer Ingelheim Dog Prescription Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Boehringer Ingelheim Dog Prescription Drugs Product Portfolio
6.10.5 Boehringer Ingelheim Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dog Prescription Drugs Industry Chain Analysis
7.2 Dog Prescription Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dog Prescription Drugs Production Mode & Process
7.4 Dog Prescription Drugs Sales and Marketing
7.4.1 Dog Prescription Drugs Sales Channels
7.4.2 Dog Prescription Drugs Distributors
7.5 Dog Prescription Drugs Customers
8 Dog Prescription Drugs Market Dynamics
8.1 Dog Prescription Drugs Industry Trends
8.2 Dog Prescription Drugs Market Drivers
8.3 Dog Prescription Drugs Market Challenges
8.4 Dog Prescription Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Dog Prescription Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Dog Prescription Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Dog Prescription Drugs Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Dog Prescription Drugs Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Dog Prescription Drugs Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Dog Prescription Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Dog Prescription Drugs Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Dog Prescription Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Dog Prescription Drugs, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Dog Prescription Drugs, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Dog Prescription Drugs, Product Type & Application
    Table 12. Global Key Manufacturers of Dog Prescription Drugs, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Dog Prescription Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dog Prescription Drugs as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Dog Prescription Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Dog Prescription Drugs Sales by Region (2019-2024) & (K Units)
    Table 18. Global Dog Prescription Drugs Sales Market Share by Region (2019-2024)
    Table 19. Global Dog Prescription Drugs Sales by Region (2025-2030) & (K Units)
    Table 20. Global Dog Prescription Drugs Sales Market Share by Region (2025-2030)
    Table 21. Global Dog Prescription Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Dog Prescription Drugs Revenue Market Share by Region (2019-2024)
    Table 23. Global Dog Prescription Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Dog Prescription Drugs Revenue Market Share by Region (2025-2030)
    Table 25. North America Dog Prescription Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Dog Prescription Drugs Sales by Country (2019-2024) & (K Units)
    Table 27. North America Dog Prescription Drugs Sales by Country (2025-2030) & (K Units)
    Table 28. North America Dog Prescription Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Dog Prescription Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Dog Prescription Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Dog Prescription Drugs Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Dog Prescription Drugs Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Dog Prescription Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Dog Prescription Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Dog Prescription Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Dog Prescription Drugs Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Dog Prescription Drugs Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Dog Prescription Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Dog Prescription Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Dog Prescription Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Dog Prescription Drugs Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Dog Prescription Drugs Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Dog Prescription Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Dog Prescription Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Dog Prescription Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Dog Prescription Drugs Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Dog Prescription Drugs Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Dog Prescription Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Dog Prescription Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Dog Prescription Drugs Sales (K Units) by Type (2019-2024)
    Table 51. Global Dog Prescription Drugs Sales (K Units) by Type (2025-2030)
    Table 52. Global Dog Prescription Drugs Sales Market Share by Type (2019-2024)
    Table 53. Global Dog Prescription Drugs Sales Market Share by Type (2025-2030)
    Table 54. Global Dog Prescription Drugs Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Dog Prescription Drugs Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Dog Prescription Drugs Revenue Market Share by Type (2019-2024)
    Table 57. Global Dog Prescription Drugs Revenue Market Share by Type (2025-2030)
    Table 58. Global Dog Prescription Drugs Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Dog Prescription Drugs Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Dog Prescription Drugs Sales (K Units) by Application (2019-2024)
    Table 61. Global Dog Prescription Drugs Sales (K Units) by Application (2025-2030)
    Table 62. Global Dog Prescription Drugs Sales Market Share by Application (2019-2024)
    Table 63. Global Dog Prescription Drugs Sales Market Share by Application (2025-2030)
    Table 64. Global Dog Prescription Drugs Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Dog Prescription Drugs Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Dog Prescription Drugs Revenue Market Share by Application (2019-2024)
    Table 67. Global Dog Prescription Drugs Revenue Market Share by Application (2025-2030)
    Table 68. Global Dog Prescription Drugs Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Dog Prescription Drugs Price (USD/Unit) by Application (2025-2030)
    Table 70. Elanco Animal Health Corporation Information
    Table 71. Elanco Animal Health Description and Business Overview
    Table 72. Elanco Animal Health Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Elanco Animal Health Dog Prescription Drugs Product
    Table 74. Elanco Animal Health Recent Developments/Updates
    Table 75. Ceva Sante Animale Corporation Information
    Table 76. Ceva Sante Animale Description and Business Overview
    Table 77. Ceva Sante Animale Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Ceva Sante Animale Dog Prescription Drugs Product
    Table 79. Ceva Sante Animale Recent Developments/Updates
    Table 80. MSD Animal Health Corporation Information
    Table 81. MSD Animal Health Description and Business Overview
    Table 82. MSD Animal Health Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. MSD Animal Health Dog Prescription Drugs Product
    Table 84. MSD Animal Health Recent Developments/Updates
    Table 85. Zoetis Corporation Information
    Table 86. Zoetis Description and Business Overview
    Table 87. Zoetis Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Zoetis Dog Prescription Drugs Product
    Table 89. Zoetis Recent Developments/Updates
    Table 90. Virbac Corporation Information
    Table 91. Virbac Description and Business Overview
    Table 92. Virbac Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Virbac Dog Prescription Drugs Product
    Table 94. Virbac Recent Developments/Updates
    Table 95. Dechra Corporation Information
    Table 96. Dechra Description and Business Overview
    Table 97. Dechra Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Dechra Dog Prescription Drugs Product
    Table 99. Dechra Recent Developments/Updates
    Table 100. Vetoquinol Corporation Information
    Table 101. Vetoquinol Description and Business Overview
    Table 102. Vetoquinol Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Vetoquinol Dog Prescription Drugs Product
    Table 104. Vetoquinol Recent Developments/Updates
    Table 105. Animalcare Group Corporation Information
    Table 106. Animalcare Group Description and Business Overview
    Table 107. Animalcare Group Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Animalcare Group Dog Prescription Drugs Product
    Table 109. Animalcare Group Recent Developments/Updates
    Table 110. Ourofino Saude Animal Corporation Information
    Table 111. Ourofino Saude Animal Description and Business Overview
    Table 112. Ourofino Saude Animal Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Ourofino Saude Animal Dog Prescription Drugs Product
    Table 114. Ourofino Saude Animal Recent Developments/Updates
    Table 115. Boehringer Ingelheim Corporation Information
    Table 116. Boehringer Ingelheim Description and Business Overview
    Table 117. Boehringer Ingelheim Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. Boehringer Ingelheim Dog Prescription Drugs Product
    Table 119. Boehringer Ingelheim Recent Developments/Updates
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. Dog Prescription Drugs Distributors List
    Table 123. Dog Prescription Drugs Customers List
    Table 124. Dog Prescription Drugs Market Trends
    Table 125. Dog Prescription Drugs Market Drivers
    Table 126. Dog Prescription Drugs Market Challenges
    Table 127. Dog Prescription Drugs Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Dog Prescription Drugs
    Figure 2. Global Dog Prescription Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Dog Prescription Drugs Market Share by Type in 2023 & 2030
    Figure 4. Oral Type Product Picture
    Figure 5. Smear Type Product Picture
    Figure 6. Injection Type Product Picture
    Figure 7. Spray Type Product Picture
    Figure 8. Global Dog Prescription Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Dog Prescription Drugs Market Share by Application in 2023 & 2030
    Figure 10. Hospital
    Figure 11. Clinic
    Figure 12. Others
    Figure 13. Global Dog Prescription Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Dog Prescription Drugs Market Size (2019-2030) & (US$ Million)
    Figure 15. Global Dog Prescription Drugs Sales (2019-2030) & (K Units)
    Figure 16. Global Dog Prescription Drugs Average Price (USD/Unit) & (2019-2030)
    Figure 17. Dog Prescription Drugs Report Years Considered
    Figure 18. Dog Prescription Drugs Sales Share by Manufacturers in 2023
    Figure 19. Global Dog Prescription Drugs Revenue Share by Manufacturers in 2023
    Figure 20. The Global 5 and 10 Largest Dog Prescription Drugs Players: Market Share by Revenue in 2023
    Figure 21. Dog Prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 22. Global Dog Prescription Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 23. North America Dog Prescription Drugs Sales Market Share by Country (2019-2030)
    Figure 24. North America Dog Prescription Drugs Revenue Market Share by Country (2019-2030)
    Figure 25. U.S. Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Canada Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Europe Dog Prescription Drugs Sales Market Share by Country (2019-2030)
    Figure 28. Europe Dog Prescription Drugs Revenue Market Share by Country (2019-2030)
    Figure 29. Germany Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. France Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. U.K. Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Italy Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Russia Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Dog Prescription Drugs Sales Market Share by Region (2019-2030)
    Figure 35. Asia Pacific Dog Prescription Drugs Revenue Market Share by Region (2019-2030)
    Figure 36. China Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Japan Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. South Korea Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. India Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Australia Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Taiwan Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Indonesia Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Thailand Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Malaysia Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Philippines Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Latin America Dog Prescription Drugs Sales Market Share by Country (2019-2030)
    Figure 47. Latin America Dog Prescription Drugs Revenue Market Share by Country (2019-2030)
    Figure 48. Mexico Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Brazil Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Argentina Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Middle East & Africa Dog Prescription Drugs Sales Market Share by Country (2019-2030)
    Figure 52. Middle East & Africa Dog Prescription Drugs Revenue Market Share by Country (2019-2030)
    Figure 53. Turkey Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. U.A.E Dog Prescription Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. Global Sales Market Share of Dog Prescription Drugs by Type (2019-2030)
    Figure 57. Global Revenue Market Share of Dog Prescription Drugs by Type (2019-2030)
    Figure 58. Global Dog Prescription Drugs Price (USD/Unit) by Type (2019-2030)
    Figure 59. Global Sales Market Share of Dog Prescription Drugs by Application (2019-2030)
    Figure 60. Global Revenue Market Share of Dog Prescription Drugs by Application (2019-2030)
    Figure 61. Global Dog Prescription Drugs Price (USD/Unit) by Application (2019-2030)
    Figure 62. Dog Prescription Drugs Value Chain
    Figure 63. Dog Prescription Drugs Production Process
    Figure 64. Channels of Distribution (Direct Vs Distribution)
    Figure 65. Distributors Profiles
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String